# Top 50 Biotech Startup Investors in Israel in October 2023

## Pontifax
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 18
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

## Trendlines Group
- Type: VC Fund
- Location: Misgav, HaZafon, Israel
- Relevant deals: 16
- Stages: Seed, Series A
- Focus: Health Care, Biotechnology, Medical Device

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

## OurCrowd
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 9
- Stages: Series B, Series A, Seed
- Focus: Software, Artificial Intelligence, Machine Learning

Access exclusive VC angel investment deals in pre-vetted startup companies. Join now.

## Israel Innovation Authority
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 8
- Stages: Grant, Seed, Pre-Seed
- Focus: Health Care, Medical Device, Software

The Israeli innovation agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

## OrbiMed
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 7
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

## Docor International Management
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 7
- Stages: Series C, Series A
- Focus: Health Care, Biotechnology, Pharmaceutical

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

## Arkin Holdings
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 6
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Medical Device

Arkin Holdings is dedicated to empowering companies that create breakthrough pharma, biotech, medical device, and digital health technologies. Our synergistic healthcare investments are focused on creating innovations that benefit humanity and enhance medical care. We offer extensive experience, with a track record of successful healthcareinvestments. Experts in the dynamic world of healthcare development, we provide the know-how and close accompaniment that helps our portfolio investments achieve substantial value and growth. Arkin Holdings currently has a healthcare portfolio of $1.5 billion through its 5 investment arms. Its investors include a substantial amount of Israel’s top-tier institutional investors.

## HBL Hadasit Bio Holdings
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 6
- Stages: Series A, Series B
- Focus: Biotechnology, Medical, Health Care

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

## aMoon Fund
- Type: VC Fund
- Location: Ra'anana, HaMerkaz, Israel
- Relevant deals: 5
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

aMoon is a leading healthtech & life sciences venture capital firm.

## Accelmed
- Type: VC Fund
- Location: Aventura, Florida, United States
- Relevant deals: 4
- Stages: Series D, Series A
- Focus: Health Care, Medical Device, Medical

Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.

## iAngels
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Artificial Intelligence, Software, FinTech

iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.

## Integra Holdings
- Type: VC Fund
- Location: Wallisellen, Zurich, Switzerland
- Relevant deals: 4
- Stages: Seed, Series B, Series F
- Focus: Biotechnology, Pharmaceutical, Life Science

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies.  
Our golden eggs    
Ayana Pharma
A late stage company with

## ZORA Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Seed, Series A, Convertible Note
- Focus: Health Care, Biotechnology, Internet

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

## Johnson & Johnson Robotics and Digital Solutions
- Type: VC Fund
- Location: New Brunswick, New Jersey, United States
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Healthcare innovation wherever it originates.

## Clal Biotechnology Industries
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI)

## Takeda Ventures
- Type: VC Fund
- Location: San Diego, California, United States
- Relevant deals: 4
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Therapeutics

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

## Ziegler Meditech Equity Partners
- Type: VC Fund
- Location: Milwaukee, Wisconsin, United States
- Relevant deals: 3
- Stages: Series C, Series E, Series F
- Focus: Health Care, Biotechnology, Mobile

ZMEP is a limited partnership focusing on equity and equity-like investments in emerging medical device technologies. ZMEP invests globally drawing on the years of investing experience of its management team. With over 50 years of experience in medical device development and commercialization, the ZMEP management team has the ability to seek outand partner with leading entrepreneurs in the medical device field. With offices in the United States and Israel, ZMEP is positioned globally to partner with middle to late stage medical device companies showing great promise for success through commercialization.

## SciSparc
- Type: VC Fund
- Location: Giv'atayim, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Corporate Round
- Focus: Pharmaceutical, Cannabis, Biopharma

SciSparc Ltd. is a specialty clinical-stage pharmaceutical company led by an experienced team of senior executives and scientists. Our focus is creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. With this focus, the company is currently engaged in the following drug development programs based ontetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol (CBD): THX-110 for the treatment of Tourette syndrome and for the treatment of obstructive sleep apnea; THX-160 for the treatment of pain; and THX-210 for the treatment of autism spectrum disorder and epilepsy.

## Sapir Venture Partners
- Type: VC Fund
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Biotechnology, Machine Learning

Early Stage VC

## Welltech Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed, Pre-Seed
- Focus: mHealth, Health Care, Biotechnology

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

## Pitango VC
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Software, Health Care, Information Technology

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

## Triventures
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Series B, Seed
- Focus: Health Care, Medical Device, Medical

Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.

## Neo Ventures
- Type: VC Fund
- Location: Sofia, Grad Sofiya, Bulgaria
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, Aerospace

Neo Ventures is the first open-ended early stage investor, based in Eastern Europe. The founders have backed more than 30 startups and exited 10 successfully. We invest in game-changing businesses, without geographic limitations. We partner with exceptional founder teams to challenge incumbents in markets ripe for change or to create entirely newmarkets. Neo Ventures funds and then supports the founders in business planning, scaling operations, follow-on investments, making the best of each opportunity and dealing with hard situations. Our investment focus is on data analytics, computer vision and remote sensing addressing disruptive opportunities across the high-growth SpaceTech, BioTech and Security verticals.

## FutuRx
- Type: VC Fund
- Location: Ness Ziona, HaMerkaz, Israel
- Relevant deals: 3
- Focus: Health Care, Biotechnology, Pharmaceutical

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

## S2G Ventures
- Type: VC Fund
- Location: Chicago, Illinois, United States
- Relevant deals: 3
- Stages: Series A, Series B, Seed
- Focus: Food and Beverage, Agriculture, Biotechnology

S2G Ventures is is a multi-stage venture fund investing in food and agriculture.  We're harnessing the power of food innovation to create better outcomes for people and the planet.

## Office of the Chief Scientist
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 3
- Stages: Seed
- Focus: Health Care, Biotechnology, Hardware

The Office of the Chief Scientist [OCS] in the Ministry of Economy is charged with execution of government policy for support of industrial R&D. The goal of the OCS is to assist in the development of technology in Israel as a means of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel’sscientific potential, enhancing the knowledge base of industry in Israel, stimulating high value-added R&D and encouraging R&D collaboration both nationally and internationally. A variety of ongoing support programs developed and offered by the OCS play a major role in enabling Israel to be a key center for high tech entrepreneurship.

## Millenium Food-Tech
- Type: VC Fund
- Relevant deals: 3
- Stages: Seed, Series A, Convertible Note
- Focus: Food and Beverage, Manufacturing, Agriculture

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

## Binder & Partners Ventures
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Information Technology, Health Care

Binder & Partners Ventures is the investments' capital arm of Binder & Partners multi-family office. The ambition of BPV is to connect our investors with the most promising startup companies.

## Amplifyher Ventures
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Health Care, E-Commerce, Fashion

Venture capital fund investing in female founders and women leaders

## NextLeap Ventures
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Big Data, Health Care

NextLeap Ventures offers investors the opportunity to invest in early stage, Israeli high-tech startups, selected through its unique, highly vetted process.

## Good Seed Ventures
- Type: VC Fund
- Location: Rheine, Nordrhein-Westfalen, Germany
- Relevant deals: 2
- Stages: Seed, Series A, Pre-Seed
- Focus: Food and Beverage, Food Processing, Biotechnology

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

## Yozma Group
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Series B, Seed
- Focus: Health Care, Medical, Software

Yozma earned worldwide recognition as the founder of Israel's VC industry. 

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

## fresh.fund
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 2
- Stages: Pre-Seed, Seed, Series A
- Focus: Health Care, FinTech, E-Learning

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio.
It's never too early to have a conversation about your startup.

## Flerie Invest
- Type: VC Fund
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.

## SCP Vitalife Partners
- Type: VC Fund
- Location: Wayne, Pennsylvania, United States
- Relevant deals: 2
- Stages: Series C, Series D
- Focus: Health Care, Medical, Medical Device

SCP Vitalife is a Life Sciences Fundformed by SCP Partners , a U.S.-based investment organization with over $900 million in venture funds under management, and Vitalife , an experienced venture firm investing primarily in Israeli medical technology companies. The SCP Vitalife team includes investment professionals with prior experiences as seniorexecutives, clinical practitioners and venture capitalists.Their focus is on early to mid-stage life science technologies and services, with a concentration on therapeutic medical devices.They will continue to follow the successful formula of their predecessor fund, Vitalife Life Sciences Fund, offering their portfolio companies hands-on strategic assistance in planning, operations and finance. From their investment experience they have developed extensive networks to access capital, recruit management and facilitate favorable strategic alliances.

## BRM Capital
- Type: VC Fund
- Location: Herzliya, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Series B, Series A
- Focus: Software, Information Technology, Internet

BRM Capital is a dynamic venture capital fund investing in early stage, Israel-related software, internet infrastructure, and communication companies. Their investment focus is on the Internet, mobile and mobile applications, digital media, online services, enterprise software, and medical device sectors and they also offer flexible, streamlinedinvestment decision making.BRM headquartered in Tel Aviv, Israel enjoys a worldwide network of industry, strategic and financial experts.

## Johnson & Johnson Innovation – JJDC
- Type: VC Fund
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

## Genesis Park
- Type: VC Fund
- Location: Houston, Texas, United States
- Relevant deals: 2
- Stages: Private Equity, Debt Financing
- Focus: Manufacturing, Health Care, Natural Resources

Genesis Park is a Houston-based private equity firm focusing on buyouts, partnering strategies with public corporations, and growth financing. We bring capital, commercial execution capabilities and a depth of experience in mergers and acquisitions.We are opportunistic within market sectors where we have depth and exposure. Those sectors includetelecommunications, energy technology and media. Energy technology is a rapidly expanding category, and our Houston base allows us to marry traditional and alternative techniques in upstream and downstream environments. Founded in 2000, Genesis Park has used discipline and patience to build value for our investors, regardless of prevailing market conditions. We are consistently active in our portfolio companies, listening, learning and adding value by working alongside management. While our preference is to partner with an existing management team, we commonly source additional talent to optimize the existing opportunity.

## The Chartered Group
- Type: VC Fund
- Relevant deals: 2
- Stages: Series A, Private Equity
- Focus: Biopharma, Agriculture, Health Care

The Chartered Group is an investment platform.

## OTV
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Health Care, Medical, Artificial Intelligence

OTV focuses on round A+ startups that aim to make a significant impact on people's lives. Our focus is on entrepreneurs with innovative ideas who are advancing the global state of well-being. Come join the digital health revolution, and be a part of transforming the healthcare industry.

## Smith & Nephew
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series B, Series C
- Focus: Medical Device, Medical, Health Care

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapysegment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

## Elron Ventures
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Information Technology, Health Care, Software

Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.

## NFX Bio
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology, Therapeutics, Medical

NFX Bio is a fund initiative that seeks to invest in scientist-founders at the seed stage with a technology platform approach.Led by Omri Amirav Drory, a venture partner with NFX, who founded Genome Compiler, it helps scientists learn to be founders and guides biology companies with information technology to be a critical distinction with massiveimplications.

## Jerusalem Global Ventures
- Type: VC Fund
- Location: Jerusalem, Yerushalayim, Israel
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Software, Information Technology, Biotechnology

Since the firm was founded in 1994, Jerusalem Global's goal has been to support private Israeli technology initiatives and to generate superior returns to investors. Over the last two decades, the partners of Jerusalem Global Ventures have developed strong ties with the top Israeli entrepreneurs and visionaries enabling JGV to invest in thebest of Israel's entrepreneurs and help their portfolio companies build winning management teams.

## HackCapital
- Type: VC Fund
- Location: Lausanne, Vaud, Switzerland
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Food and Beverage, Biotechnology, Food Processing

Join FoodTech focused investors looking to back impact-driven founders shaping our food system

## Howard Morgan
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Artificial Intelligence, Health Care

Howard Morgan is currently the Chairman of B Capital. He co-founded First Round Capital with Josh Kopelman as the first professional Seed Stage Fund, where he remains Senior Advisor. Prior to First Round, Howard helped found Idealab with Bill Gross, and served as President of Renaissance Technologies, which he co-founded with Jim Simons. Prior tohis move into the business of technology, Howard served as a professor at the Wharton School and the Moore School, both at the University of Pennsylvania, as well as at Cornell University. He is also an Executive Fellow at UC Berkeley.
Howard’s research on user interface technology and the optimization of computer networks was critical to bringing the ARPAnet to Philadelphia in the 1970s. Through this early internet participation, he helped corporate and government agencies use technology to improve the efficiency of both large and small organizations. He also has deep experience with very large databases, and served as the first Editor of the ACM Transactions on Database Systems Journal.
Throughout his career, Howard has sought out great people and nurtured them so that they could realize their dreams. His mentees have included both PhD students researching a key topic, and early stage entrepreneurs building companies and taking them from seed stage through initial public offerings. He currently serves as a Director of Idealab, and he is on the board of several non-profits including Cold Spring Harbor Laboratories and Math For America. He has also served on a number of public company Boards, including Franklin Electronic Publishers and Internet Brands, Inc. He was CEO of Kentek and Franklin during various turnover or transitional periods and in 1997 he was named Delaware Valley Entrepreneur of the Year. Howard is a respected author and a frequent speaker at major industry conferences.
Howard received a PhD in Operations Research from Cornell University in 1968, and a BS in Physics from City College of the City University of New York in 1965.

## ALIVE Israel HealthTech Fund
- Type: VC Fund
- Location: Tel Aviv, Tel Aviv, Israel
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Medical, Biotechnology

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

## DSM Venturing
- Type: VC Fund
- Location: Heerlen, Limburg, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Manufacturing

DSM Venturing provides start-up funding, coaching and support for start-up companies that share our purpose of creating brighter lives for all.

## Eddy Shalev
- Type: Angel
- Relevant deals: 2
- Stages: Seed, Series B, Series A
- Focus: Software, Information Technology, Enterprise Software

Eddy Shalev is an angel investor. Eddy is one of the best-known figures in the Israeli business community. Since the beginning of Israel's venture capital industry, Eddy has focused on private-equity investments in the high-tech sector, and has played a key role in several high-profile success stories, including Fundtech, ParadigmGeophysical and Orbot Instruments. Eddy is currently on the board of Aternity, Profitect and Sensible Medical.Eddy has been an active private equity investor in Israel since 1992, when he began a private equity investment program that invested in early-stage Israeli high-tech companies. Beginning in 1985, Eddy led the Israeli affiliates of Oscar Gruss and Sons Inc., and then later CIBC-Oppenheimer, where he directed the firm’s corporate banking, sales and trading, and equity research for Israeli companies traded on NASDAQ.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co